GlassScriptMammomat B.Brilliant
Payments companies reported to CMS as associated with Mammomat B.Brilliant. "Associated with" is CMS's wording: it links a payment to a product without saying the money was spent on it.
By year
Payments reported as associated with Mammomat B.Brilliant, per program year, as reported to CMS.
Who makes it
Specialties most often involved
Where the associated payments went, by the receiving clinician's specialty.
Clinicians most associated with Mammomat B.Brilliant
These are the largest totals companies reported as associated with Mammomat B.Brilliant. They are typically speaking or consulting arrangements, which companies must report by law; appearing here is not evidence of anything improper.
| Clinician | Location | Specialty | Associated payments (2023-2025) |
|---|---|---|---|
| Chirag Parghi | Spring, TX | Diagnostic Radiology | $10,277.71 |
| Laurie Margolies | New York, NY | Diagnostic Radiology | $5,054.56 |
| Andrea Lamphiear | Iowa City, IA | Diagnostic Radiology | $4,597.30 |
| Noel Bergquist | Knoxville, TN | Diagnostic Radiology | $2,925.47 |
| Tanya Moseley | Houston, TX | Diagnostic Radiology | $2,600.88 |
| Elsa Kuhl | Louisville, KY | Diagnostic Radiology | $2,515.16 |
| Cindy Lee | Stony Brook, NY | Diagnostic Radiology | $2,190.87 |
| Lisa Stempel | Chicago, IL | Diagnostic Radiology | $2,112.12 |
| Melinda Staiger | Holmdel, NJ | Diagnostic Radiology | $2,108.29 |
| Benjamin Pettus | Newport News, VA | Diagnostic Radiology | $2,017.41 |
Prescribed Mammomat B.Brilliant?
See what its makers reported for your doctor. Two steps, private, no account.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.